<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">31293181</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>13</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1366-5804</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals</Title>
                <ISOAbbreviation>Biomarkers</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Renalase in children with chronic kidney disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>638-644</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/1354750X.2019.1642957</ELocationID>
            <Abstract>
                <AbstractText><b>Background:</b> Renalase is kidney-derived molecule initially considered as catecholamine-inactivating enzyme. However, recent studies suggest that renalase exerts potent cardio- and nephroprotective actions, not related to its enzymatic activity. <b>Purpose:</b> To assess renalase level in children with chronic kidney disease (CKD). <b>Material and methods:</b> Serum renalase, BMI, arterial stiffness, peripheral and central blood pressure, intima-media thickness (IMT), medications, and biochemical parameters were analyzed in 38 children with CKD (12.23âÂ±â4.19âyears) (stage G2-5). Control group consisted of 38 healthy children. <b>Results:</b> In the study group, GFR was 25.74âÂ±â8.94âmL/min/1.73 m<sup>2</sup>; 6 children were dialyzed; 26 had arterial hypertension. Renalase level was higher in the study group compared to control group (<i>pâ&lt;</i>â0.001). In CKD children renalase correlated (<i>pâ&lt;</i>â0.05) with BMI <i>Z</i>-score (<i>râ=</i>â-0.36), alfacalcidol dose (<i>râ=</i>â0.41), GFR (<i>râ=</i>â-0.69), hemoglobin (<i>râ=</i>â-0.48), total cholesterol (<i>râ=</i>â0.35), LDL-cholesterol (<i>râ=</i>â0.36), triglycerides (<i>râ=</i>â0.52), phosphate (<i>râ=</i>â0.35), calcium-phosphorus product (<i>râ=</i>â0.35), parathormone (<i>râ=</i>â0.58), and pulse wave velocity <i>Z</i>-score (<i>râ=</i>â0.42). In multivariate analysis GFR (<i>Î²â=</i>â-0.63, <i>pâ&lt;</i>â0.001), triglycerides (<i>Î²â=</i>â0.59, <i>pâ=</i>â0.002), and alfacalcidol dose (<i>Î²â=</i>â-0.49, <i>pâ=</i>â0.010) were determinants of renalase. <b>Conclusions:</b> In children with CKD there is a strong correlation between renalase level and CKD stage. Furthermore, in these patients renalase does not correlate with blood pressure but may be a marker of arterial stiffness.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Skrzypczyk</LastName>
                    <ForeName>Piotr</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1959-8255</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics and Nephrology, Medical University of Warsaw , Warsaw , Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okarska-NapieraÅa</LastName>
                    <ForeName>Magdalena</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1668-6302</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics and Nephrology, Medical University of Warsaw , Warsaw , Poland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics with Observational Unit, Medical University of Warsaw , Warsaw , Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stelmaszczyk-Emmel</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3667-1220</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw , Warsaw , Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>GÃ³rska</LastName>
                    <ForeName>ElÅ¼bieta</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw , Warsaw , Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>PaÅczyk-Tomaszewska</LastName>
                    <ForeName>MaÅgorzata</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4566-7074</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics and Nephrology, Medical University of Warsaw , Warsaw , Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biomarkers</MedlineTA>
            <NlmUniqueID>9606000</NlmUniqueID>
            <ISSNLinking>1354-750X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006887">Hydroxycholecalciferols</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.4.3.4</RegistryNumber>
                <NameOfSubstance UI="D008995">Monoamine Oxidase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.4.3.4.</RegistryNumber>
                <NameOfSubstance UI="C521557">renalase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>URQ2517572</RegistryNumber>
                <NameOfSubstance UI="C008088">alfacalcidol</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050071" MajorTopicYN="N">Bone Density Conservation Agents</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006887" MajorTopicYN="N">Hydroxycholecalciferols</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008995" MajorTopicYN="N">Monoamine Oxidase</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059289" MajorTopicYN="N">Vascular Stiffness</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adolescents</Keyword>
            <Keyword MajorTopicYN="N">arterial stiffness</Keyword>
            <Keyword MajorTopicYN="N">blood pressure</Keyword>
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">chronic kidney disease</Keyword>
            <Keyword MajorTopicYN="N">renalase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>7</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>2</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>7</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31293181</ArticleId>
            <ArticleId IdType="doi">10.1080/1354750X.2019.1642957</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>